Fumitomo Odawara
Director/Miembro de la Junta en KAINOS LABORATORIES, INC. .
Cargos activos de Fumitomo Odawara
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| KAINOS LABORATORIES, INC. | Director/Miembro de la Junta | 01/06/2019 | - |
Asahi Kasei Pharma Corp.
 Asahi Kasei Pharma Corp. Investment ManagersFinance Part of Asahi Kasei Corp., Asahi Kasei Pharma Corp. is a pharmaceutical and diagnostic company based in Tokyo, Japan. Asahi Kasei Pharma operates in the healthcare business unit of the Asahi Kasei Group, with a mission to sincerely care for each individual life and solve their unmet medical needs with a wealth of ideas and solid science. Asahi Kasei Corp. is a US $20 billion Japanese technology company that provides innovative, science-based solutions to a diverse range of markets including healthcare, chemicals and fibers, housing and construction materials, and electronics. Founded in 2003, the company has developed innovative drugs in the fields of orthopedics, acute care, neurology (including pain), and immunology. | Corporate Officer/Principal | 01/06/2006 | - |
Historial de carrera de Fumitomo Odawara
Estadísticas
Internacional
| Japón | 3 |
Operativa
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 2 |
| Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| KAINOS LABORATORIES, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Asahi Kasei Pharma Corp.
Asahi Kasei Pharma Corp. Investment ManagersFinance Part of Asahi Kasei Corp., Asahi Kasei Pharma Corp. is a pharmaceutical and diagnostic company based in Tokyo, Japan. Asahi Kasei Pharma operates in the healthcare business unit of the Asahi Kasei Group, with a mission to sincerely care for each individual life and solve their unmet medical needs with a wealth of ideas and solid science. Asahi Kasei Corp. is a US $20 billion Japanese technology company that provides innovative, science-based solutions to a diverse range of markets including healthcare, chemicals and fibers, housing and construction materials, and electronics. Founded in 2003, the company has developed innovative drugs in the fields of orthopedics, acute care, neurology (including pain), and immunology. | Finance |
- Bolsa de valores
- Insiders
- Fumitomo Odawara
- Experiencia